NM_138425.4:c.86C>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_138425.4(C12orf57):​c.86C>T​(p.Ala29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000399 in 1,613,384 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00022 ( 2 hom. )

Consequence

C12orf57
NM_138425.4 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 3.43

Publications

4 publications found
Variant links:
Genes affected
C12orf57 (HGNC:29521): (chromosome 12 open reading frame 57) This gene is ubiquitously expressed in human tissues. It is required for development of the human corpus callosum. Mutations in this gene are associated with Temtamy syndrome (TEMTYS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
C12orf57 Gene-Disease associations (from GenCC):
  • temtamy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009012699).
BP6
Variant 12-6944509-C-T is Benign according to our data. Variant chr12-6944509-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210550.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00215 (327/152366) while in subpopulation AFR AF = 0.00673 (280/41592). AF 95% confidence interval is 0.00608. There are 1 homozygotes in GnomAd4. There are 142 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C12orf57NM_138425.4 linkc.86C>T p.Ala29Val missense_variant Exon 2 of 3 ENST00000229281.6 NP_612434.1 Q99622

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C12orf57ENST00000229281.6 linkc.86C>T p.Ala29Val missense_variant Exon 2 of 3 1 NM_138425.4 ENSP00000229281.5 Q99622

Frequencies

GnomAD3 genomes
AF:
0.00215
AC:
327
AN:
152248
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00675
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000511
AC:
128
AN:
250504
AF XY:
0.000376
show subpopulations
Gnomad AFR exome
AF:
0.00637
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000530
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000216
AC:
316
AN:
1461018
Hom.:
2
Cov.:
32
AF XY:
0.000191
AC XY:
139
AN XY:
726814
show subpopulations
African (AFR)
AF:
0.00562
AC:
188
AN:
33448
American (AMR)
AF:
0.000559
AC:
25
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53300
Middle Eastern (MID)
AF:
0.000953
AC:
5
AN:
5246
European-Non Finnish (NFE)
AF:
0.0000549
AC:
61
AN:
1111964
Other (OTH)
AF:
0.000580
AC:
35
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00215
AC:
327
AN:
152366
Hom.:
1
Cov.:
33
AF XY:
0.00191
AC XY:
142
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00673
AC:
280
AN:
41592
American (AMR)
AF:
0.00222
AC:
34
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68036
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000783
Hom.:
1
Bravo
AF:
0.00247
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00431
AC:
19
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000610
AC:
74
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Aug 04, 2022
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1 -

Jun 02, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
May 09, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

C12orf57-related disorder Benign:1
Feb 22, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Temtamy syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T;T;T;T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.086
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.75
.;T;T;T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.0090
T;T;T;T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
1.1
L;.;.;L
PhyloP100
3.4
PROVEAN
Benign
-1.2
N;.;N;N
REVEL
Benign
0.27
Sift
Benign
0.31
T;.;T;T
Sift4G
Benign
0.51
T;T;T;T
Polyphen
0.0070
B;.;B;B
Vest4
0.10, 0.19, 0.097
MVP
0.80
MPC
0.15
ClinPred
0.048
T
GERP RS
3.7
PromoterAI
0.014
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.16
gMVP
0.38
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139938808; hg19: chr12-7053672; API